Mobic is used in the treatment of osteoarthritis; rheumatoid arthritis; juvenile rheumatoid arthritis and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Mobic 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Mobic Information for Consumers
- Mobic Information for Healthcare Professionals (includes dosage details)
- Side Effects of Mobic (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Updated 13 Aug 2017 • 3 answers
Updated 1 Dec 2010 • 1 answer
Updated 21 Jun 2015 • 1 answer
Updated 5 Oct 2012 • 1 answer
Updated 26 Oct 2014 • 1 answer